Form 8-K - Current report:
SEC Accession No. 0001193125-25-021348
Filing Date
2025-02-06
Accepted
2025-02-06 08:01:27
Documents
14
Period of Report
2025-02-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d898732d8k.htm   iXBRL 8-K 32352
5 GRAPHIC g898732dsp004.jpg GRAPHIC 53822
  Complete submission text file 0001193125-25-021348.txt   293749

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20250206.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20250206_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20250206_pre.xml EX-101.PRE 11260
17 EXTRACTED XBRL INSTANCE DOCUMENT d898732d8k_htm.xml XML 3668
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 25595518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)